SEARCH

SEARCH BY CITATION

References

  • 1
    British Committee for Standards in Haematology. Investigation and management of heritable thrombophilia. Br J Haematol 2001; 114: 51228.
  • 2
    Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395403.
  • 3
    Pabinger I, Schneider B. Thrombotic risk of women with hereditary antithrombin III, protein C and protein S deficiency taking oral contraceptive medication: the GTH Study Group on Natural Inhibitors. Thromb Haemost 1994; 71: 54852.
  • 4
    Rosendaal FR. Oral contraceptives and screening for factor V Leiden. Thromb Haemost 1996; 75: 5245.
  • 5
    Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 2000; 160: 4952.
  • 6
    Gerhardt A, Scharf RE, Beckmann MQ, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V Leiden mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 37480.
  • 7
    Scurr JH, Machin SJ, Bailey-King S, Mackie IJ, McDonald S, Coleridge Smith PD. Frequency and prevention of symptomless deep vein thrombosis in long haul flights: a randomised trial. Lancet 2001; 357: 14859.
  • 8
    Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 2000; 356: 1823.
  • 9
    Björgell O, Nilsson PE, Nilsson JA, Svensson PJ. Location and extent of deep vein thrombosis in patients with and without FV-R 506Q mutation. Thromb Haemost 2000; 83: 64851.
  • 10
    Turkstra F, Karemaker R, Kiujer PMM, Prins MH, Buller HR. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolus and deep vein thrombosis really different? Thromb Haemost 1999; 81: 3458.
  • 11
    Sarasin FP, Bounameaux H. Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis. Br Med J 1998; 316: 959.
  • 12
    Greaves M, Baglin T. Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease. Br J Haematol 2000; 109: 699703.